#Keyfindings
-The predominance of serotypes V, Ia, and III accounting for three-quarters of maternal and neonatal isolates strongly supports multivalent vaccine formulations.
-Current pentavalent/hexavalent vaccines [candidate] targeting these serotypes would provide substantial coverage.

#Criticalconsiderations
-Serotype V showed the highest genetic diversity with 30 sequence types, suggesting evolutionary adaptability.
-Serotype III demonstrated low diversity with ST-17 constituting 78.3% of isolates, indicating clonal dominance.
-Dominant clonal complexes CC17 and CC23 account for over half of isolates, with CC17 being hypervirulent and strongly associated with neonatal invasive disease.

#PreventionStrategyImplications
-The high vertical transmission rate (47%) and limited implementation of intrapartum antibiotic prophylaxis (IAP) in Africa emphasize maternal vaccination as a sustainable long-term strategy.
-Low β-lactam resistance supports current IAP recommendations using penicillin and ampicillin.
-However, genetic diversity in serotype V necessitates continuous genomic surveillance to monitor potential serotype replacement or capsular switching post-vaccination.